Shanghai Kindly Entrp Dvlp Grp
Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sales medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags. The company also provides including medical packing films, sterilization indicator tapes and needles; and intervention accessories, such as stopcocks. In addit… Read more
Shanghai Kindly Entrp Dvlp Grp (603987) - Net Assets
Latest net assets as of September 2025: CN¥3.05 Billion CNY
Based on the latest financial reports, Shanghai Kindly Entrp Dvlp Grp (603987) has net assets worth CN¥3.05 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.24 Billion) and total liabilities (CN¥1.19 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.05 Billion |
| % of Total Assets | 72.0% |
| Annual Growth Rate | 16.58% |
| 5-Year Change | -1.93% |
| 10-Year Change | 265.05% |
| Growth Volatility | 21.4 |
Shanghai Kindly Entrp Dvlp Grp - Net Assets Trend (2011–2024)
This chart illustrates how Shanghai Kindly Entrp Dvlp Grp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shanghai Kindly Entrp Dvlp Grp (2011–2024)
The table below shows the annual net assets of Shanghai Kindly Entrp Dvlp Grp from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.91 Billion | +4.70% |
| 2023-12-31 | CN¥2.78 Billion | +9.02% |
| 2022-12-31 | CN¥2.55 Billion | -24.80% |
| 2021-12-31 | CN¥3.39 Billion | +14.26% |
| 2020-12-31 | CN¥2.97 Billion | +9.99% |
| 2019-12-31 | CN¥2.70 Billion | +65.66% |
| 2018-12-31 | CN¥1.63 Billion | +21.38% |
| 2017-12-31 | CN¥1.34 Billion | +9.20% |
| 2016-12-31 | CN¥1.23 Billion | +54.12% |
| 2015-12-31 | CN¥797.08 Million | +18.54% |
| 2014-12-31 | CN¥672.40 Million | +28.25% |
| 2013-12-31 | CN¥524.30 Million | +15.05% |
| 2012-12-31 | CN¥455.71 Million | +15.14% |
| 2011-12-31 | CN¥395.78 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Kindly Entrp Dvlp Grp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1440.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.43 Billion | 56.28% |
| Common Stock | CN¥441.00 Million | 17.36% |
| Other Comprehensive Income | CN¥4.05 Million | 0.16% |
| Other Components | CN¥665.34 Million | 26.20% |
| Total Equity | CN¥2.54 Billion | 100.00% |
Shanghai Kindly Entrp Dvlp Grp Competitors by Market Cap
The table below lists competitors of Shanghai Kindly Entrp Dvlp Grp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Luoyang Northglass Technology Co Ltd
SHE:002613
|
$317.38 Million |
|
Ningbo Daye Garden Machinery Co Ltd
SHE:300879
|
$317.38 Million |
|
Eco-Shop Marketing Berhad
KLSE:5337
|
$317.39 Million |
|
Southern Sun Limited
F:JK9
|
$317.45 Million |
|
Tus Pharmaceutical Group Co Ltd
SHE:000590
|
$317.08 Million |
|
Novavest Real Estate Ag
SW:NREN
|
$317.04 Million |
|
Camelot Electronics Technology Co. Ltd. A
SHE:301282
|
$317.01 Million |
|
Berli Jucker PCL
BK:BJC
|
$316.94 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Kindly Entrp Dvlp Grp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,405,601,602 to 2,539,635,805, a change of 134,034,203 (5.6%).
- Net income of 215,328,192 contributed positively to equity growth.
- Dividend payments of 94,033,095 reduced retained earnings.
- Other comprehensive income increased equity by 1,022,988.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥215.33 Million | +8.48% |
| Dividends Paid | CN¥94.03 Million | -3.7% |
| Other Comprehensive Income | CN¥1.02 Million | +0.04% |
| Other Changes | CN¥11.72 Million | +0.46% |
| Total Change | CN¥- | 5.57% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Kindly Entrp Dvlp Grp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.59x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.14x to 1.59x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥1.13 | CN¥9.21 | x |
| 2012-12-31 | CN¥1.29 | CN¥9.21 | x |
| 2013-12-31 | CN¥1.49 | CN¥9.21 | x |
| 2014-12-31 | CN¥1.88 | CN¥9.21 | x |
| 2015-12-31 | CN¥2.18 | CN¥9.21 | x |
| 2016-12-31 | CN¥3.23 | CN¥9.21 | x |
| 2017-12-31 | CN¥2.79 | CN¥9.21 | x |
| 2018-12-31 | CN¥3.08 | CN¥9.21 | x |
| 2019-12-31 | CN¥3.68 | CN¥9.21 | x |
| 2020-12-31 | CN¥4.00 | CN¥9.21 | x |
| 2021-12-31 | CN¥4.71 | CN¥9.21 | x |
| 2022-12-31 | CN¥5.05 | CN¥9.21 | x |
| 2023-12-31 | CN¥5.52 | CN¥9.21 | x |
| 2024-12-31 | CN¥5.78 | CN¥9.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Kindly Entrp Dvlp Grp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.48%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.52%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 1.63x
- Recent ROE (8.48%) is below the historical average (13.23%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 20.21% | 9.71% | 0.87x | 2.41x | CN¥38.03 Million |
| 2012 | 13.28% | 6.45% | 0.91x | 2.26x | CN¥14.08 Million |
| 2013 | 12.83% | 6.79% | 0.82x | 2.30x | CN¥13.95 Million |
| 2014 | 10.37% | 6.56% | 0.79x | 2.01x | CN¥2.29 Million |
| 2015 | 13.09% | 8.91% | 0.78x | 1.88x | CN¥22.34 Million |
| 2016 | 8.84% | 8.90% | 0.73x | 1.36x | CN¥-13.19 Million |
| 2017 | 9.67% | 9.47% | 0.78x | 1.30x | CN¥-4.10 Million |
| 2018 | 10.71% | 10.14% | 0.67x | 1.58x | CN¥9.74 Million |
| 2019 | 15.49% | 13.68% | 0.48x | 2.35x | CN¥88.07 Million |
| 2020 | 18.53% | 12.34% | 0.62x | 2.42x | CN¥150.20 Million |
| 2021 | 20.18% | 13.54% | 0.62x | 2.39x | CN¥211.48 Million |
| 2022 | 13.97% | 10.00% | 0.75x | 1.85x | CN¥88.64 Million |
| 2023 | 9.60% | 9.41% | 0.58x | 1.75x | CN¥-9.66 Million |
| 2024 | 8.48% | 9.52% | 0.55x | 1.63x | CN¥-38.64 Million |
Industry Comparison
This section compares Shanghai Kindly Entrp Dvlp Grp's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Kindly Entrp Dvlp Grp (603987) | CN¥3.05 Billion | 20.21% | 0.39x | $317.14 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |